SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-070820
Filing Date
2022-11-10
Accepted
2022-11-10 07:43:47
Documents
14
Period of Report
2022-11-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea168353-8k_cormedix.htm   iXBRL 8-K 24880
2 PRESS RELEASE DATED NOVEMBER 10, 2022 ea168353ex99-1_cormedix.htm EX-99.1 58977
3 GRAPHIC ex99-1_001.jpg GRAPHIC 18326
  Complete submission text file 0001213900-22-070820.txt   291227

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE crmd-20221110.xsd EX-101.SCH 3227
5 XBRL LABEL FILE crmd-20221110_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE crmd-20221110_pre.xml EX-101.PRE 22359
8 EXTRACTED XBRL INSTANCE DOCUMENT ea168353-8k_cormedix_htm.xml XML 3593
Mailing Address 300 CONNELL DRIVE SUITE 4200 BERKELEY HEIGHTS NJ 07922
Business Address 300 CONNELL DRIVE SUITE 4200 BERKELEY HEIGHTS NJ 07922 908-517-9500
CorMedix Inc. (Filer) CIK: 0001410098 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34673 | Film No.: 221374984
SIC: 2834 Pharmaceutical Preparations